Oncocytic cardiomyopathy is a rare arrhythmogenic disorder usually associated with female sex, difficult-to-control arrhythmias, or sudden death of infants and children. Morphologically, it is characterized by the presence of oncocytic cells, which are diffusely distributed or form the nodular structures within the myocardium, occasionally involving the valves, with a large number of mitochondria in cytoplasms. We present two cases of oncocytic cardiomyopathy. The first case had a fatal clinical outcome, and the other case was surgically treated. The nuclear expression of skeletal muscle transcription factor MyoD1 was demonstrated in the first case, supporting the theory that oncocytic cardiomyopathy is a conduction system developmental disorder. To confirm this hypothesis, it is necessary to further investigate myogenic transcription factor program in human cardiac conduction system cells.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.prp.2004.01.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Histiocytoid cardiomyopathy presenting as sudden death in an 18-month-old infant.
Forensic Sci Med Pathol
September 2024
Victorian Institute of Forensic Medicine, Melbourne, VIC, Australia.
Histiocytoid cardiomyopathy (HC) is an arrhythmogenic disorder, usually involving children under two years of age with a strong Caucasian and female predominance. The disease is fatal in the vast majority and diagnosis is nearly always established at autopsy, but this is only possible with adequate myocardial sampling. Meticulous gross and histological examination of the heart in collaboration with a cardiovascular-trained pathologist maximises the opportunity to make specific diagnoses (and therefore rule out the differentials of SIDS, SUDC and child abuse), guide genetic testing, and inform potentially life-saving medical interventions for blood relations.
View Article and Find Full Text PDFBiventricular Assist Device Support for Intractable Arrhythmias From Histiocytoid Cardiomyopathy.
ASAIO J
November 2022
From the Pediatric Cardiology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
Histiocytoid cardiomyopathy (HICMP) is a rare mitochondrial cardiomyopathy associated with recurrent life-threatening arrhythmias and variable degrees of systolic dysfunction. Successful heart transplantation for HICMP has been described, but there has been no published experience with biventricular assist device (BiVAD) support for intractable arrhythmias in HICMP. We report a 13 month old girl with left ventricular noncompaction and preserved systolic function who presented in cardiogenic shock secondary to incessant ventricular arrhythmias.
View Article and Find Full Text PDFA Unique Case of Sudden Cardiac Death in an Infant.
Clin Pediatr (Phila)
February 2019
4 Children's Hospital of Michigan, Detroit, MI, USA.
Anaesthetic Management of a Patient with Left Ventricular Non-Compaction Undergoing Laparotomy.
J Coll Physicians Surg Pak
September 2018
Department of Anaesthesia, Southport and Ormskirk NHS Hospitals, UK.
We report a case of left ventricular non-compaction as patient underwent laparotomy for ovarian cystectomy. Left ventricular non-compaction is a rare congenital cardiomyopathy with clinical features of heart failure, systemic thromboembolic events and arrhythmias. Perioperative management of these patients can be very challenging.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!